Total raised
$53.4M
Last: SAFE 2024-03
Stage
Series C
Founded
2017
Headcount
50
HQ
Binyamina-Giv'at Ada
Sector
Health Tech & Life Sciences
About
OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. The company aims to understand the patient's unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment.
OncoHost developed the PROphet platform. Combining bioinformatics, system biology, proteomic pattern recognition and machine learning, PROphet provides clinicians with actionable clinical insights, optimal choice of therapy, and a better understanding of their patients' personalized cancer dynamics.
Funding history · 6 rounds · $53.4M total
2024-03
SAFE
Undisclosed
2023-12
SAFE
Undisclosed
2022-05
Series C
$35.0M
2021-01
Series B
$8.0M
2019-05
Series A
$5.0M
2017-10
Seed
$1.6M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is OncoHost's primary focus in the medical field?
- OncoHost is a technology company focused on transforming precision medicine for improved patient outcomes in oncology. They aim to understand patient responses to therapy to overcome treatment resistance.
- What is the name of OncoHost's core technology platform?
- OncoHost developed the PROphet platform, which combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide clinical insights and aid in therapy selection.
- When was OncoHost founded?
- OncoHost was founded in April 2017.
- What was OncoHost's total funding raised as of the latest data?
- OncoHost has raised a total of $53.4 million USD. For a full financing history, please refer to startupim.
- Which investor participated in multiple funding rounds for OncoHost?
- OurCrowd participated in multiple funding rounds for OncoHost, including Series B, Series C, and two SAFE rounds.
- When did OncoHost receive its Series C funding, and who was a lead investor?
- OncoHost received its Series C funding in May 2022, with ALIVE Israel Healthtech Fund as a lead investor.
- What significant grant did OncoHost receive in January 2020?
- In January 2020, OncoHost and RayBiotech were awarded a $1 million grant from the BIRD Foundation to advance precision oncology for patients receiving immunotherapy.
- Where is OncoHost's headquarters located?
- OncoHost's headquarters is located in Binyamina-Giv'at Ada, Israel.
- What was a notable partnership announced by OncoHost in October 2023?
- In October 2023, Henlius and OncoHost partnered to predict trial outcomes using machine learning.
- What award did OncoHost win in January 2023?
- In January 2023, OncoHost won the BIG Innovation Award for its PROphet platform.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMoleculesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2CB2BB2C
Highlights
1 PatentsVerified
Tags
pharmaceuticalsoncologycancerpersonalized-medicinediagnosticsdata-analyticsartificial-intelligenceblood-testmachine-learningcancer-therapybioinformaticstreatmentsdecision-supportdigital-healthcarebioconvergenceimmunotherapyclinical-trials